Nektar Therapeutics NKTR Holds Steady Near Support Amid Low Volatility Prediction Markets Spark Legal Clashes Between States and Federal Regulators URGN Q1 2026 Earnings Narrower Loss Beats Estimates Shares Slip Despite Surprise Dells Earnings Blowout Reinforces AI Investment Trend Market Momentum Favors Tech Sector